Evidence map›Paper›PMID 31930569›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2020

Reciprocal upregulation of hypoxia-inducible factor-1α and persistently enhanced placental adenosine signaling contribute to the pathogenesis of preeclampsia.

Takayuki Iriyama, Wei Wang, Nicholas F Parchim, Seisuke Sayama, Keiichi Kumasawa, Takeshi Nagamatsu, Anren Song, Yang Xia, Rodney E Kellems

Open access · bronzeAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Trophoblast adaptation to hypoxia: balance and dysfunction.Cell communication and signaling : CCS · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Takayuki IriyamaDepartment of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Wei WangDepartment of Biochemistry and Molecular Biology, The University of Texas McGovern Medical School, Houston, TX, USA.
Nicholas F ParchimDepartment of Biochemistry and Molecular Biology, The University of Texas McGovern Medical School, Houston, TX, USA.
Seisuke SayamaDepartment of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Keiichi KumasawaDepartment of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Takeshi NagamatsuDepartment of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Anren SongDepartment of Biochemistry and Molecular Biology, The University of Texas McGovern Medical School, Houston, TX, USA.
Yang XiaDepartment of Biochemistry and Molecular Biology, The University of Texas McGovern Medical School, Houston, TX, USA.
Rodney E KellemsDepartment of Biochemistry and Molecular Biology, The University of Texas McGovern Medical School, Houston, TX, USA.
The University of Texas Health Science Center at Houston · USThe University of Tokyo · JPCentral South University · CNUniversity of New Mexico Hospital · US

Funding

Autoantibodies in Preeclampsia: Pre-symptomatic markers and therapeutic targetsRC4HD067977 · NICHD · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI KELLEMS, RODNEY E, XIA, YANG · 2010 to 2010
$1.8M
NICHD NIH HHS RC4 HD067977
6 · The paper itself

Abstract

Recent evidence indicates that elevated placental adenosine signaling contributes to preeclampsia (PE). However, the molecular basis for the chronically enhanced placental adenosine signaling in PE remains unclear. Here, we report that hypoxia-inducible factor-1α (HIF-1α) is crucial for the enhancement of placental adenosine signaling. Utilizing a pharmacologic approach to reduce placental adenosine levels, we found that enhanced adenosine underlies increased placental HIF-1α in an angiotensin receptor type 1 receptor agonistic autoantibody (AT

Indexed as

AdenosineAnimalsAutoantibodiesBlood PressureFemaleHumansHypoxia-Inducible Factor 1, alpha SubunitImmunoblottingImmunohistochemistryMiceMice, Inbred C57BLPlacentaPre-EclampsiaPregnancyReverse Transcriptase Polymerase Chain ReactionRNA, Small InterferingAdenosineAutoantibodiesFlt1 protein, mouseHypoxia-Inducible Factor 1, alpha SubunitRNA, Small InterferingVascular Endothelial Growth Factor Receptor-1adenosine signalingangiotensin II type I receptor agonistic autoantibody (AT1-AA)hypoxia-inducible factor-1αpreeclampsiatumor necrosis factor superfamily member 14 (TNFSF14)

Identifiers

PMID31930569
PMCPMC7060108
OpenAlexW2999666436

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.